The continued exploration of modernizing clinical trials 

The need for an alternative to the paper-based clinical trial process is long overdue. Not only is the original method cost- and labor-intensive, but it can delay new drug development, as well. The first siteless technology model for clinical trial research was introduced last year, and since then studies in this area continue. At the 3rd Annual Clinical Trials Patient Experience Summit, held recently in California, industry leaders discussed the potential impact the changes to a siteless clinical trial model may have on the patient.

Diaceutics, BioReference Laboratories partnership is evidence of shift to Big Data clinical applications

In a serious commitment to take some of the hit-and-miss out of current practices that impact the rollout of new drugs, Diaceutics and BioReference Laboratories have signed a five-year collaborative agreement. The agreement will give Diaceutics access to 50,000 patient samples a day through BioReference’s network of 30,000 healthcare providers. The goals of the just announced partnership are far reaching beyond just improving patient outcomes.

To read the full articles for this issue of The CenterWatch Weekly, please click here for subscription information